amyloid protein inhibitor (NCATS)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameamyloid protein inhibitor (NCATS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules modulatorsBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 proteinCell adhesion molecules
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Center For Advancing Translational Sciences
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A